Literature DB >> 32311642

Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts.

Gert Jan Lammers1, Claudio L A Bassetti2, Leja Dolenc-Groselj3, Poul J Jennum4, Ulf Kallweit5, Ramin Khatami6, Michel Lecendreux7, Mauro Manconi8, Geert Mayer9, Markku Partinen10, Giuseppe Plazzi11, Paul J Reading12, Joan Santamaria13, Karel Sonka14, Yves Dauvilliers15.   

Abstract

The aim of this European initiative is to facilitate a structured discussion to improve the next edition of the International Classification of Sleep Disorders (ICSD), particularly the chapter on central disorders of hypersomnolence. The ultimate goal for a sleep disorders classification is to be based on the underlying neurobiological causes of the disorders with clear implication for treatment or, ideally, prevention and or healing. The current ICSD classification, published in 2014, inevitably has important shortcomings, largely reflecting the lack of knowledge about the precise neurobiological mechanisms underlying the majority of sleep disorders we currently delineate. Despite a clear rationale for the present structure, there remain important limitations that make it difficult to apply in routine clinical practice. Moreover, there are indications that the current structure may even prevent us from gaining relevant new knowledge to better understand certain sleep disorders and their neurobiological causes. We suggest the creation of a new consistent, complaint driven, hierarchical classification for central disorders of hypersomnolence; containing levels of certainty, and giving diagnostic tests, particularly the MSLT, a weighting based on its specificity and sensitivity in the diagnostic context. We propose and define three diagnostic categories (with levels of certainty): 1/"Narcolepsy" 2/"Idiopathic hypersomnia", 3/"Idiopathic excessive sleepiness" (with subtypes).
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cataplexy; Classification; Diagnosis; Excessive daytime sleepiness; Fatigue; Hypersomnia; Hypersomnolence; MSLT; Narcolepsy; Sleep; Sleep inertia

Mesh:

Year:  2020        PMID: 32311642     DOI: 10.1016/j.smrv.2020.101306

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  13 in total

1.  Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia.

Authors:  Anna Laura Rassu; Elisa Evangelista; Lucie Barateau; Sofiene Chenini; Régis Lopez; Isabelle Jaussent; Yves Dauvilliers
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

Review 2.  Epidemiology, Physiology and Clinical Approach to Sleepiness at the Wheel in OSA Patients: A Narrative Review.

Authors:  Maria R Bonsignore; Carolina Lombardi; Simone Lombardo; Francesco Fanfulla
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

3.  The Impact of Sleep Pattern in School/Work Performance During the COVID-19 Home Quarantine in Patients With Narcolepsy.

Authors:  Mengke Zhao; Baokun Zhang; Jiyou Tang; Xiao Zhang
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

4.  The growing toolkit for evaluation of central disorders of hypersomnolence.

Authors:  David T Plante
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

5.  Misdiagnosis of narcolepsy caused by a false-positive orexin-A/hypocretin-1 enzyme immune assay.

Authors:  Tomi Sarkanen; Gabriele Sved; Maria Juujärvi; Anniina Alakuijala; Markku Partinen
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

Review 6.  Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria.

Authors:  Michel Billiard; Karel Sonka
Journal:  Nat Sci Sleep       Date:  2022-02-26

7.  Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.

Authors:  Kiran P Maski; Alicia Colclasure; Elaina Little; Erin Steinhart; Thomas E Scammell; William Navidi; Cecilia Diniz Behn
Journal:  Sleep       Date:  2021-07-09       Impact factor: 6.313

8.  Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.

Authors:  Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

Review 9.  Narcolepsy type 1: what have we learned from genetics?

Authors:  Hanna M Ollila
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

10.  Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.

Authors:  Yutaka Natori; Eisaku Sasaki; Shu Soeda; Shigenori Furukawa; Yusuke Azami; Emi Tokuda; Takashi Kanbayashi; Shigehira Saji
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.